Product Reports Resources Pricing Login Book a demo

Phylos Bioscience

Food · Portland, United States · Founded 2014

Cannabis genetics company that empowers growers of all sizes to produce high quality cannabis in a cost-effective way MoreLess

Phylos Bioscience operates at the intersection of agricultural science and data technology, focusing specifically on the cannabis and hemp industries. Founded in 2014 by Nishan Karassik and Mowgli Holmes, the company initially aimed to create a comprehensive genetic map of the cannabis plant, similar to a 23andMe for cannabis. Nishan Karassik's background in technology and sustainable agriculture, combined with Mowgli Holmes's expertise as a molecular biologist, provided the foundational knowledge for this endeavor. Holmes, who holds a PhD from Columbia University, was driven by the potential to apply modern genomic science to a plant with a long, yet poorly documented, history of cultivation.

The company's core business revolves around providing genomic testing and data services to cultivators, breeders, and researchers within the cannabis market. Its primary offering is a suite of genetic tests that can identify a plant's lineage, cannabinoid and terpene profiles, and sex. This information empowers growers to make more informed decisions, optimize their cultivation practices for desired traits, and protect their intellectual property. The business model is primarily service-based, generating revenue from the sale of these testing kits and the associated data analysis. Phylos serves a diverse clientele, ranging from large-scale commercial growers to smaller craft producers and research institutions.

A significant development in the company's trajectory was the introduction of its own proprietary cannabis seeds. This move represented a strategic pivot from being purely a data and testing provider to also becoming a direct supplier of plant genetics. This vertical integration allows Phylos to leverage its vast genetic database to breed new varieties with specific, commercially desirable characteristics, such as high yields or specific chemical profiles. This expansion into seed production provides a new and substantial revenue stream, positioning the company as a key player in the supply chain for cannabis cultivation. The company's database, known as The Phylos Galaxy, has been a central part of its identity, mapping the genetic relationships between thousands of cannabis strains and making this information accessible to its clients.

Keywords: cannabis genetics, hemp genomics, agricultural biotechnology, plant breeding, genetic testing, seed production, cultivation data, molecular biology, crop science, agritech

Company overview

Phylos Bioscience company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2014
Headquarters
Portland, United States
Employees
49
Open positions
None listed
Dealroom signal
72.6
client focusb2bsub industryAgriTechbusiness modelManufacturingsectorTestingsectorBiotechnologysectorResearch and DevelopmentsectorCannabissectorBiotech and PharmasectorHard Techsectormedical testingsectorDT and LSsectorscience-basedindustryFood

Valuation & funding

Phylos Bioscience funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEEquity / VC Jul 2024 $1M OrganiGram
CONVERTIBLEEquity / VC Nov 2023 $2.8M OrganiGram
CONVERTIBLEEquity / VC May 2023 $3.3M OrganiGram
LATE VCEquity / VC Feb 2023 $4.5M $38M Undisclosed
LATE VCEquity / VC Feb 2022 $7.6M $30M Accomplice · Merida Capital Partners · Entourage Effect Capital
OtherOther financing Apr 2019 Undisclosed
SERIES CEquity / VC Apr 2017 Slow Ventures
SEEDEquity / VC Feb 2015 Undisclosed
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 49
2025 48
2024 49
2023 44
2022 30
2021 31
2020 36
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Phylos Bioscience website traffic

Latest recorded traffic for Phylos Bioscience is 17K monthly website visits, up 153.7% over the last three months. Phylos Bioscience's team grew 2.1% over the past year.

Latest monthly visits17K 3-month web change+153.7% 1-year team growth+2.1%
Monthly website visits102 observations · Oct 2017–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Phylos Bioscience compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Phylos Bioscience's talent

Book a demo to see the people
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Phylos Bioscience's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 1 investor entered at this stage
OrganiGram
Series B+ 4 investors entered at this stage
Slow Ventures
Merida Capital Partners
Accomplice
Entourage Effect Capital
Other known 1 additional known investor
Big Rock

Global footprint

Where Phylos Bioscience has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Phylos Bioscience

Recent press, funding announcements, and product moves mentioning Phylos Bioscience — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Phylos Bioscience

An AI-synthesized read of the highest-engagement posts about Phylos Bioscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phylos Bioscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.